Study on the Mass Balance of [14C] CMS-D002 in Healthy Adult Participants in China

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This phase 1, single-group study will evaluate the mass balance of \[14C\] CMS-D002 after a single oral dose in healthy adult participants in China. The study will assess total radioactivity recovery and routes of excretion, characterize whole-blood and plasma pharmacokinetics, and determine metabolite profiles and major biotransformation pathways.
Epistemonikos ID: 1f0bae6194e063392ac8723c248737e6d668b729
First added on: Aug 26, 2026